Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Merlin for Recurrent Herpes Labialis
NCT03192306Phase 2Completed
- Sponsor
- Topical Remedy
- Start
- Jul 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Aftera in herpes labialis, sponsored by Topical Remedy. Started Jul 2017; status: completed.
02
Drugs
Aftera
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT03192306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192306.